Pricing Log in Create free account

Lunai Bioworks Inc. (LNAI) vs Matinas Biopharma Holdings, Inc. (MTNB)

Lunai Bioworks Inc. and Matinas Biopharma Holdings, Inc. are both Biotechnology companies. Matinas Biopharma Holdings, Inc. is the larger, with a market value of $1.1M against $830.0K — 1.4× the size. Matinas Biopharma Holdings, Inc. has the higher net margin (0.00% vs −3,761.9%) and the lower return on invested capital (−419.3% vs 0.00%). Across the 15 metrics below, Lunai Bioworks Inc. leads on 8 and Matinas Biopharma Holdings, Inc. on 7.

Valuation

Metric LNAI MTNB Biotechnology median
P/E n/m n/m 10.60
P/S 5.68 0.12 9.40
P/B n/m 0.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.04 0.66
EV/Sales 0.25 (0.06) 9.02
Earnings yield (640.81%) (1,403.30%) (32.88%)
Free cash flow yield (988.00%) (1,142.24%) (23.13%)

Profitability

Metric LNAI MTNB Biotechnology median
Gross margin (3.48%) 0.00% 68.51%
Operating margin (9,184.79%) 0.00% 0.00%
Net margin (3,761.88%) 0.00% 0.00%
Free cash flow margin (5,610.24%) 0.00% 0.00%
Return on equity 23.46% (154.28%) (51.96%)
Return on assets (39.21%) (98.53%) (46.06%)
Return on invested capital 0.00% (419.27%) 0.00%

Growth

Metric LNAI MTNB Biotechnology median
Revenue growth (TTM) — 2,135.91% 6.76%
EPS growth (last fiscal year) 98.77% 59.84% 29.88%
Revenue growth, 5-year CAGR — 55.69% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LNAI MTNB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.11 0.85 4.97
Net debt to EBITDA 0.20 0.62 1.01

Dividend

Metric LNAI MTNB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LNAI MTNB Biotechnology median
Market cap 830.00k 1.14m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack